Safety Information in Drug Approval Paper

Safety Information in Drug Approval Paper

Table of Contents

Order Number	Y47874HDUEW
Type of Project	Essay/Research Paper
Writer Level	PHD/MASTERS
Writing Style	APA/Harvard/MLA/CHICAGO
Citations	5
Page Count	3-15

Description/Paper Instructions

Safety Information in Drug Approval Paper

 

In completing Writing Assignment students will have the opportunity to:

 

Demonstrate an understanding of the basic principles of what encompasses safety science with respect to drug/biologics development

 

Demonstrate an ability to extract and interpret safety-relevant information form the publicly available FDA Drug Approval Package Information

 

Demonstrate an ability to describe/analyze safety information for an approved drug/biologic/device

 

For this assignment, you are a Sr Manager of Regulatory Affairs at a small, emerging biotechnology company that is looking to develop a new, inhaled treatment for Parkinson’s Disease.  Your company is very small and

inexperienced and so far, none of the nonclinical safety testing or clinical testing of this new drug has begun. As your team members prepare to start nonclinical safety testing and then clinical testing of the drug, it is your task to

provide your colleagues with a summary of how nonclinical and clinical data is used to inform the development of safety information about your new Parkinson’s disease drug.  You also need to provide your colleagues with

background information on the regulatory aspects of safety monitoring, using the safety guidance provided by FDA and ICH.

 

During your research to learn more about drugs that treat Parkinson’s, you discover that there is already a marketed product for Parkinson’s that is also administered by inhaler.  The already approved drug is called Inbrija (also

known as CVT-301 – the research code name). This is great news!  You can use this similar, already-approved drug as a comparison for your investigational inhaled therapeutic for Parkinson’s.

 

There is a lot of information your company can learn about how to safely develop your planned novel Parkinson’s therapeutic by studying the FDA’s published NDA approval information located on the FDA’s database of approved

products:  https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/209184Orig1s000TOC.cfm (Links to an external site.).  Specifically, you can learn a lot about the safety information that was included in the NDA for Inbrija

by reviewing information contained in the following FDA Application review Files:

 

Your task is to provide the following information to your colleagues (incorporation of figures and graphs HIGHLY encouraged):

 

Part 1: Background information:

 

Overview of Safety Basics: A description of the basic principles of generating safety information about drugs/biologics from nonclinical and clinical studies that are relevant to a drug’s development. You may wish to include a

description of why safety monitoring is a critical component of nonclinical and clinical development of a drug so that your colleagues fully understand the importance.

 

Regulatory information: Describe for your colleagues the different ICH and FDA guidance documents that are available to help you navigate the regulatory requirements with respect to safety monitoring from the nonclinical and

clinical development perspectives. The ICH’s M3(R2) (Links to an external site.) is a useful tool that you can describe for your colleagues to help them understand nonclinical safety requirements that must be completed prior to

and during clinical testing of the drug.  You can also navigate to the FDA’s Safety Reporting requirements for INDs (Links to an external site.) and describe some of the requirements for clinical safety monitoring.

 

Part II: Pulling out relevant examples from the Inbrija FDA approval package

 

Nonclinical safety information: Using the “Pharmacology Review” file for Inbrija’s NDA approval package, describe what kinds of safety pharmacology and general toxicology studies were run.  You can describe the number of

studies in each nonclinical safety category as well as what species they were run in and the basic results/findings of these studies.  You are encouraged to include tables and figures from the Pharmacology Review in your written

summary, just be sure to include citations.

 

Clinical safety information: Using the “Medical Review” file, describe some of the safety information that was generated as part of the clinical trials that were implemented when Inbrija was being developed. You should include a

brief list/description of all the clinical trials that were run.

 

Part III: Conclusions: This section should be at least one paragraph and should work to summarize next steps for your company with respect to developing the nonclinical and clinical safety program for your novel Parkinson’s

disease therapeutic.

 

Safety Information in Drug Approval Paper

Excellent	The essay demonstrates exemplary comprehension of the relevant content by thoroughly as well as correctly discussing the relevant information; identifying as well as explaining all of the 3 fundamental aspects; using correct terminology; describing the reasoning next to key points/claims; as well as substantiating points with several accurate as well as illuminating examples, as necessary or useful. There are no gaps in the necessary answer.
Good	Scholarly sources that are credible are employed to successfully support statements that are, as the most part, clear as well as fairly expressed. With just a few minor inaccuracies, APA 6th Edition is utilized. There are a few small typos in the references and/or citations. There is some reliance on dubious sources.
Satisfactory	Because of certain improper terminology and/or confusing wording, the work is frequently confused and difficult to understand; thoughts may be disjointed, meandering, and/or repetitious. a lack of structure; and/or grammatical, spelling, and punctuation mistakes.
Poor	The essay demonstrates a lack of understanding of the related documents by failing to address or improperly addressing the relevant; failing to identify or incorrectly trying to explain key concepts/ideas; ignoring as well as incorrectly attempting to explain key points/claims as well as the rationale behind them; and/or inaccurately or improperly using terminology.
No Response	Essay displays great writing abilities, such as a clear as well as thought-provoking thesis, suitable and effective organization, vibrant and persuasive supporting materials, good diction as well as sentence skills, and faultless or almost perfect mechanics, such as spelling and grammar. The essay flawlessly achieves the assignment’s objectives.
Quality of Response	Because of its intelligent growth and mature manner, this study merits attention. It provides a compelling analysis of or reaction to the text, expanding on that response using well-chosen examples and arguments. The sixth paper demonstrates that its author can typically use appropriate words, employ advanced phrases successfully, and adhere to written English rules.
Delivery Timeline	3 hours – 24 hours
Backlinks	www.crucialessay.com/orders/ordernow/www.contentexpertagencies.com/orders/ordernow

 

PLACE THE ORDER WITH US TODAY AND GET A PERFECT SCORE!!!

Do You Have Any Other Essay/Assignment/Class Project/Homework Related to this? Click Here Now [CLICK ME] and Have It Done by Our PhD Qualified Writers!!

Why Work With Us!!

• Tired of getting an average grade in all your school assignments, projects, essays, and homework? Try us today for all your academic schoolwork needs. We are among the most trusted and recognized professional writing services in the market.

• We provide unique, original and plagiarism-free high quality academic, homework, assignments and essay submissions for all our clients. At our company, we capitalize on producing A+ Grades for all our clients and also ensure that you have smooth academic progress in all your school term and semesters.

• High-quality academic submissions, A 100% plagiarism-free submission, Meet even the most urgent deadlines, Provide our services to you at the most competitive rates in the market, Give you free revisions until you meet your desired grades and Provide you with 24/7 customer support service via calls or live chats.